高级检索
当前位置: 首页 > 详情页

Efficacy and Safety of Telitacicept in Early SLE

文献详情

编号/登记号:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究类型:
研究参与人:
研究单位: [1]Peking Union Medical College Hospital [2]RemeGen Co., Ltd. [3]Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,Beijing,China,100730 [4]Peking University Third Hospital,Beijing,China [5]Fuyang People's Hospital,Fuyang,China [6]Guangdong Provincial People's Hospital,Guangzhou,China [7]Nanfang Hospital, Southern Medical University,Guanzhou,China [8]Qilu Hospital of Shandong University,Jinan,China [9]the First People's Hospital of Yunnan Province,Kunming,China [10]The Second Affiliated Hospital of Lanzhou University,Lanzhou,China [11]The Affiliated Hospital of Nantong University,Nantong,China [12]the Affiliated Hospital of Qingdao University,Qingdao,China [13]The Second Hospital of Hebei Medical University,Shijiazhuang,China [14]The First Affiliated Hospital of Soochow University,Suzhou,China [15]Shanxi Baiqiuen Hospital,Taiyuan,China [16]First Affiliated Hospital of Xinjiang Medical University,Urumqi,China [17]Weifang People's Hospital,Weifang,China [18]Tongji Hospital, Tongji Medical College,,Wuhan,China [19]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan,China [20]Wuxi Second People's Hospital,Wuxi,China [21]the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,China [22]The First Affiliated Hospital of Zhengzhou University,Zhenzhou,China

关键词: Lupus Erythematosus Systemic Telitacicept

研究目的:
The purpose of this study is to evaluate the safety and efficacy of Telitacicept in adult patients with early stage of SLE .

资源点击量:82325 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号